LCN2 and relapsing-remitting multiple sclerosis: To give more insight about the redox control of LCN2 induction in dysfunctional adipocytes, we aimed at using dimethylfumarate (DMF), a fumaric acid ester approved for the treatment of relapsing-remitting MS, which promote Nrf2-mediated antioxidant defense [44,45].